HPCM
MRNA icon

Hunter Perkins Capital Management’s Moderna MRNA Stock Holding History

Hunter Perkins Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-950
Closed -$241K – 90
2021
Q4 		$241K Sell
950
-400
-30% -$117K 0.05% 79
2021
Q3 		$520K Sell
1,350
-150
-10% -$55.3K 0.11% 56
2021
Q2 		$352K Sell
1,500
-300
-17% -$53.6K 0.07% 72
2021
Q1 		$236K Sell
1,800
-200
-10% -$29K 0.05% 80
2020
Q4 		$209K Buy
+2,000
New +$202K 0.04% 164

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hunter Perkins Capital Management's MRNA Position: Q1 2022 in Review

Hunter Perkins Capital Management sold out of Moderna (MRNA) in Q1 2022, closing a stake of 950 shares — an estimated $241K sold.

Hunter Perkins Capital Management first reported a position in MRNA in Q4 2020 and held it in 5 quarters. The position peaked at $520K in Q3 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Hunter Perkins Capital Management reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Hunter Perkins Capital Management sold 950 Moderna shares in Q1 2022, an estimated $241K.
  • Hunter Perkins Capital Management first reported a position in Moderna in Q4 2020 and held it in 5 quarters.
  • Hunter Perkins Capital Management's Moderna position peaked at $520K in Q3 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Hunter Perkins Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.